Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia-Reference-Cited by-同舟云学术

Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia

Published:2011-03 Issue:2 Volume:23 Page:197-202
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:

Author:

Horwitz Mitchell E

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference28 articles.

1. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases;Slavin;Blood,1998

2. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy;Giralt;Blood,1997

3. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival;Valcarcel;J Clin Oncol,2008

4. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors;Hegenbart;J Clin Oncol,2006

5. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research;Giralt;Biol Blood Marrow Transplant,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Transplant for Acute Lymphoblastic Leukemia;Basics of Hematopoietic Stem Cell Transplant;2023

2. Stem Cell Therapy and Innate Lymphoid Cells;Stem Cells International;2022-08-02

3. Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD;Blood Advances;2021-11-16

4. Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS‐EB ‐1 or MDS‐EB ‐2;International Journal of Cancer;2021-05-28

5. Myeloablative Versus Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis;Indian Journal of Hematology and Blood Transfusion;2020-11-20